Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.04 (-4.63%)
Close on Nov 20, 2026Market cap $559.40MP/E –Yield –
Geron shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Geron's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 667M, up 3.2% from the year before. Over ten years it grew 15.1% a year on average. The highest annual figure on record is 667M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 667M | +3.2% |
| FY2024 | Dec 31, 2024 | 646M | +13.2% |
| FY2023 | Dec 31, 2023 | 571M | +49.9% |
| FY2022 | Dec 31, 2022 | 381M | +16.2% |
| FY2021 | Dec 31, 2021 | 328M | +20.7% |
| FY2020 | Dec 31, 2020 | 271M | +42.8% |
| FY2019 | Dec 31, 2019 | 190M | +7.7% |
| FY2018 | Dec 31, 2018 | 177M | +10.9% |
| FY2017 | Dec 31, 2017 | 159M | +0.1% |
| FY2016 | Dec 31, 2016 | 159M | -2.2% |
| FY2015 | Dec 31, 2015 | 163M | +5.9% |
| FY2014 | Dec 31, 2014 | 154M | +19.6% |
| FY2013 | Dec 31, 2013 | 128M | +1.1% |
| FY2012 | Dec 31, 2012 | 127M | +2.0% |
| FY2011 | Dec 31, 2011 | 125M | +27.6% |
| FY2010 | Dec 31, 2010 | 98M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1M | +0.7% |
| Q1 FY2026 | Mar 31, 2026 | 1M | +0.5% |
| Q4 FY2025 | Dec 31, 2025 | 667M | +0.5% |
| Q3 FY2025 | Sep 30, 2025 | 667M | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | 1M | -99.9% |
| Q1 FY2025 | Mar 31, 2025 | 1M | -99.9% |
| Q4 FY2024 | Dec 31, 2024 | 664M | +11.6% |
| Q3 FY2024 | Sep 30, 2024 | 662M | +14.3% |
| Q2 FY2024 | Jun 30, 2024 | 654M | +19.5% |
| Q1 FY2024 | Mar 31, 2024 | 603M | +10.8% |
| Q4 FY2023 | Dec 31, 2023 | 595M | +56.2% |
| Q3 FY2023 | Sep 30, 2023 | 580M | +43.0% |
| Q2 FY2023 | Jun 30, 2023 | 547M | +35.5% |
| Q1 FY2023 | Mar 31, 2023 | 544M | +64.0% |
| Q4 FY2022 | Dec 31, 2022 | 381M | +15.2% |
| Q3 FY2022 | Sep 30, 2022 | 405M | +23.2% |
| Q2 FY2022 | Jun 30, 2022 | 404M | +23.5% |
| Q1 FY2022 | Mar 31, 2022 | 332M | +2.6% |
| Q4 FY2021 | Dec 31, 2021 | 331M | +3.7% |
| Q3 FY2021 | Sep 30, 2021 | 329M | +3.2% |
| Q2 FY2021 | Jun 30, 2021 | 327M | +32.4% |
| Q1 FY2021 | Mar 31, 2021 | 324M | +61.6% |
| Q4 FY2020 | Dec 31, 2020 | 319M | +60.8% |
| Q3 FY2020 | Sep 30, 2020 | 319M | +68.6% |
| Q2 FY2020 | Jun 30, 2020 | 247M | +32.4% |
| Q1 FY2020 | Mar 31, 2020 | 200M | +7.4% |
| Q4 FY2019 | Dec 31, 2019 | 199M | +6.5% |
| Q3 FY2019 | Sep 30, 2019 | 189M | +2.6% |
| Q2 FY2019 | Jun 30, 2019 | 187M | +6.9% |
| Q1 FY2019 | Mar 31, 2019 | 186M | +16.1% |
| Q4 FY2018 | Dec 31, 2018 | 186M | +17.0% |
| Q3 FY2018 | Sep 30, 2018 | 184M | +15.8% |
| Q2 FY2018 | Jun 30, 2018 | 174M | +9.6% |
| Q1 FY2018 | Mar 31, 2018 | 161M | +0.9% |
| Q4 FY2017 | Dec 31, 2017 | 159M | +0.1% |
| Q3 FY2017 | Sep 30, 2017 | 159M | +0.0% |
| Q2 FY2017 | Jun 30, 2017 | 159M | – |
| Q1 FY2017 | Mar 31, 2017 | 159M | – |
| Q4 FY2016 | Dec 31, 2016 | 159M | – |
| Q3 FY2016 | Sep 30, 2016 | 159M | – |
See a number that looks wrong?